TABLE 1.
Protein 1-protein 2 | Life stage(s) | Major function(s) | Positions in protein 1 (reference[s]) | Positions in protein 2 (reference[s]) | Reference(s) |
---|---|---|---|---|---|
GP120-GP41 | Entry, budding | Promotes viral entry, promotes viral budding, promotes Env packaging | 31–46, 50–54, 70–75, 84–89, 91, 103, 106, 107, 110, 111, 114, 215, 220–224, 226, 244, 246, 489–505 (50) | 520–528, 530, 533, 534, 536, 537, 540, 541, 543–546, 569–572, 574, 575, 577–579, 581, 582, 585, 586, 588–592, 593, 596–598, 601–610, 614, 617–619, 622, 623, 628, 629, 631–633, 635, 636, 639, 642, 643, 646, 650, 651, 654, 658, 659, 661–663 (50) | 48–58 |
GP41Env-matrix | Entry, budding | Promotes viral entry, promotes Env packaging | 712, 713–856 (70, 84); 764–856 (591); 814–844 (73) | 12, 30, 34 (76); 18, 20, 22, 32, 33 (83, 592); 6, 29, 31, 62 (74); 49 (84); 62 (72); 84, 99 (75) | 69–76, 83, 84, 591, 592 |
GP120-Tat | Entry | Promotes viral entry | 166–171 (89); 157–171 (86) | 73–86 (86) | 86, 89 |
RT-integrase | Reverse transcription, integration | Enhances RT activity, inhibits integrase activity | 1–242, 387–421 (108) | 201–288 (108); 243, 250, 258, 220–270 (102); 213–288 (106) | 102, 106, 108 |
RT-nucleocapsid | Reverse transcription | Enhances RT activity | 548–560, p51 domain (113) | 13–30, 34–51 (110, 111) | 110, 111, 113 |
RT-Vif | Reverse transcription | Enhances RT activity | ? | 161–164 | 131 |
RT-Tat | Reverse transcription | Enhances RT activity | ? | 49–57 | 139 |
RT-Nef | Reverse transcription | Enhances RT activity | p51 domain | 154–172 | 148 |
Protease-Tat | Reverse transcription | Protease cleaves Tat to enhance reverse transcription | Protease catalytic site | 49–57 | 152 |
Integrase-Rev | Integration | Inhibits integrase activity | 66–80, 118–128 (173) | 12–23, 53–67 (173) | 173–175, 180 |
Integrase-matrix | Integration | Enhances nuclear import of the PIC | 50–212 | 132 | 181 |
Matrix-Vpr | Integration | Enhances nuclear import of the PIC | 88–132 | ? | 183 |
Integrase-Nef | Integration | ? | ? | 58–206 | 149 |
Tat-Vpr | Transcription | Enhances viral transcription | 50–67 | ? | 220 |
Tat-Rev | Transcription | Proteasomal degradation of Tat | ? | 35–50 | 216 |
Tat-Nef | Transcription | Enhanced viral transcription | ? | ? | 223 |
Tat-nucleocapsid | Transcription | NC induces Tat degradation | ? | ? | 228 |
Vif-Vpr | Transcription | Vif mediates Vpr degradation | ? | ? | 232 |
NCGag-Vif | Budding | Vif packaging, viral core stability, inhibits PR cleavage | 44–55 (301) | 75–114 (300) | 300, 301, 303 |
NCGag-Vpr | Budding | Vpr packaging | 13–30, 34–51 | 70–80 | 313 |
p6Gag-Vpr | Budding | Vpr packaging | 15–18 (329); 32–46 (325); 34–36 (326); 35–47 (330); 41–46 (322) | 18–34 (322); 1–71 (327) | 322, 325–327, 329, 330 |
p6Gag-Vpx | Budding | Vpx packaging | 15–40 (333) | 73–89 (333) | 314, 332, 333 |
GP41Env-Nef | Budding | Env packaging | 712–715 | 181–210 | 336 |
Gag-RT | Budding | RT packaging | 183–305 (347) | ? | 347, 348 |
Protease-Gag/GagPol | Maturation | Gag and GagPol cleavage | Protease catalytic site | Gag/GagPol cleavage sites | 495–497 |
Protease-Vif | Maturation | Inhibits protease activity | 1–9 (516, 517) | 30–65 (519); 41–65 (520); 78–98 (516); 81–88, 88–98 (521) | 516, 517, 519–521 |
Protease-RT | Maturation | Protease cleaves RTGagPol, RT promotes protease activity, protease inhibits RT activity | Protease catalytic site | 440 | 441 | 522, 593 |
Protease-Nef | Maturation | Protease cleaves Nef, Nef inhibits protease activity | Protease catalytic site | 57 | 58 | 528 |
Protease-GP41CT | Maturation | Protease cleaves GP41CT | Protease catalytic site | 714 | 715, 716 | 717 | 538 |
A question mark indicates that the corresponding information is not available. A vertical line indicates a protease cleavage site (e.g., 57 | 58 suggests that HIV protease cleaves the substrate protein between amino acid positions 57 and 58). Position indices of GP120 and GP41 are based on the Env protein sequence in the HIV-1 HXB2 reference strain. Except for HIV-2 Vpx, interaction domains are reported for HIV-1.